Go Symbol Lookup
Loading...

Drug Giant Looking At Several Acquisitions

 Text Size  
Published: Friday, 2 Jul 2010 | 5:29 PM ET
Lee Brodie By:

Producer

Despite a terrible tape, the Biotech ETF closed higher after chatter suggested a major drug maker is looking to make at least one if not several acquisitions. What must you know?

According to published reports the board of French drugmaker Sanofi-Aventis talked about making several U.S. acquisitions when they met in Paris earlier this week; including one or two that could be worth at least $15 billion.

On the news shares of Biogen, Botox maker Allergan and Genzyme all shot higher.

Sanofi declined comment.

Fast Flash
The Euro turns this week.

What’s must you know before you trade?

Biotech was hot on Friday because of this Sanofi story, says ISI Group biotech analyst Dr. Mark Schoenebaum.

Retail investors should know the sector has dramatically underperformed because of concerns drugs made by these companies are expensive.

I think it will be hard for biotech to get out of the funk, says Schoenebaum. However there’s no denying that the group is cheap.

If you want to take a stab at a cheap stock in the space, look at Celgene , adds Guy Adami.


______________________________________________________
Got something to to say? Send us an e-mail at fastmoney-web@cnbc.com and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send those e-mails to fastmoney@cnbc.com.

Trader disclosure: On July 2, 2010, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders: Adami Owns (AGU), (C), (GS), (INTC), (MSFT), (NUE), (BTU); Terranova Owns (FCX), (MON), (AGU), (KO), (XOM), (TEVA), (RDS.A), (GMCR), (UPL), (GS); Terranova is short gold; Terranova owns (GLD) July 123 puts; Terranova owns (GS) JULY 130 CALLS; Terranova owns (GS) JULY 135 CALLS; Najarian Owns (PFE); Najarian Owns (CELG); Grasso owns (ASTM), (ABK), (BAC), (BGP), (C), (CSCO), (DYN), (JPM), (LPX), (MO), (NDAQ), (PFE), (PRST)

For Joe Terranova
Terranova works for (VRTS)
Terranova is chief market strategist of Virtus Investment Partners, LTD.
Virtus Investment Partners owns more than 1% of (CASS)
Virtus Investment Partners owns more than 1% of (LDR)
Virtus Investment Partners owns more than 1% of (LPHI)
Virtus Investment Partners owns more than 1% of (MGRC)
Virtus Investment Partners owns more than 1% of (XLB)
Virtus Investment Partners owns more than 1% of (XLP)
Virtus Investment Partners owns more than 1% of (XLY)
Virtus Investment Partners owns more than 1% of (XLI)
Virtus Investment Partners owns more than 1% of (XLK)
Virtus Investment Partners owns more than 1% of (XLU)
Virtus Investment Partners owns more than 1% of (SUBK)
Virtus Investment Partners owns more than 1% of (WDFC)
Virtus Investment Partners owns more than 1% of (YDNT)
Virtus Investment Partners owns more than 1% of (DRYS)

For Steve Grasso
Stuart Frankel & Co and it’s partners own (BAX)
Stuart Frankel & Co and it’s partners own (COG)
Stuart Frankel & Co and it’s partners own (CUBA)
Stuart Frankel & Co and it’s partners own (DHR)
Stuart Frankel & Co and it’s partners own (DYN)
Stuart Frankel & Co and it’s partners own (GERN)
Stuart Frankel & Co and it’s partners own (HSPO)
Stuart Frankel & Co and it’s partners own (IP)
Stuart Frankel & Co and it’s partners own (MERC)
Stuart Frankel & Co and it’s partners own (NWS.A)
Stuart Frankel & Co and it’s partners own (NYX)
Stuart Frankel & Co and it’s partners own (PDE)
Stuart Frankel & Co and it’s partners own (PFE)
Stuart Frankel & Co and it’s partners own (PRST)
Stuart Frankel & Co and it’s partners own (RDC)
Stuart Frankel & Co and it’s partners own (SYMC)
Stuart Frankel & Co and it’s partners own (TBT)
Stuart Frankel & Co and it’s partners own (TLM)
Stuart Frankel & Co and it’s partners own (TRV)
Stuart Frankel & Co and it’s partners own (XRX)
Stuart Frankel & Co and it’s partners own (SDS)
Stuart Frankel & Co and it’s partners are short (QQQQ)
Stuart Frankel & Co and it’s partners are short (AAPL)

For Patty Edwards
Edwards Owns (PM)
Edwards Owns (AAPL) For Clients
Edwards Owns (AMGN) For Clients
Edwards Owns (AMZN) For Clients
Edwards Owns (BA) For Clients
Edwards Owns (BAC) For Clients
Edwards Owns (C) For Clients
Edwards Owns (CELG) For Clients
Edwards Owns (DO) For Clients
Edwards Owns (EBAY) For Clients
Edwards Owns (FCX) For Clients
Edwards Owns (GLD) For Clients
Edwards Owns (GOOG) For Clients
Edwards Owns (HD) For Clients
Edwards Owns (JPM) For Clients
Edwards Owns (MS) For Clients
Edwards Owns (MSFT) For Clients
Edwards Owns (QQQQ) For Clients
Edwards Owns (SPY) For Clients
Edwards Owns (WFC) For Clients
Edwards Owns (WMT) For Clients
Edwards Owns (YHOO) For Clients
Edwards Owns (VXX) For Clients
Edwards Owns (PM) For Clients

For Brian Kelly
Kelly Is Short (GS)
Accounts Managed By Kanundrum Capital Are Short (FCX)
Accounts Managed By Kanundrum Capital Are Short (USO)
Accounts Managed By Kanundrum Capital Are Short (XLF)
Accounts Managed By Kanundrum Capital Are Short (PCAR)
Accounts Managed By Kanundrum Capital Are Short (WYNN)
Accounts Managed By Kanundrum Capital Are Short (XLF)
Accounts Managed By Kanundrum Capital Are Short (XLI)
Accounts Managed By Kanundrum Capital Are Short (XLK)
Accounts Managed By Kanundrum Capital Are Short (EWI)
Accounts Managed By Kanundrum Capital Are Short (EWO)
Accounts Managed By Kanundrum Capital Are Short (BUCY)
Accounts Managed By Kanundrum Capital Are Short (MCO)
Accounts Managed By Kanundrum Capital Are Short (NATI)
Accounts Managed By Kanundrum Capital Are Short (RSX)
Accounts Managed By Kanundrum Capital Are Long Euro
Accounts Managed By Kanundrum Capital Own (SDS)

For Anthony Scaramucci
Scaramucci Owns (GS), Skybridge Owns (GS)
Scaramucci Owns (C), Skybridge Owns (C)
Scaramucci Owns (BAC), Skybridge Owns (BAC)

Brian Nagel
***No Disclosures On BBBY, WSM, LTM, PIR

Mark Schoenebaum
ISI Does And Seeks To Do Business With (GILD), (CELG), (GENZ), Has Recieved Non-Investment Banking Compensation In Past 12 Months

Mark Chandler
***No Disclosures

Mike Boyd
***No Dislcosures



CNBC.com with wires

 Print
Chatter that a major drug maker is looking to make at least one if not several acquisitions sent biotech surging. What must you know?
  Price   Change %Change
AEF ---
BIIB ---
CELG ---
IBB ---
SNI ---

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

Contact Fast Money

  • Showtimes

    Halftime Report - Weekdays 12p ET
    Fast Money - Weekdays 5p ET
  • Lee is host on CNBC's “Fast Money,” and “Options Action.”

  • Wapner is an award-winning reporter and the host of "Fast Money Halftime Report." He has also reported documentaries for CNBC.

  • Adami is a contributor on CNBC's "Fast Money." He is also Managing Director of stockMONSTER.com.

  • Najarian, the "Pit Boss," is cofounder of optionMONSTER.com, a news site for options traders.

  • Finerman is President of Metropolitan Capital Advisors, Inc., a company she co-founded.

  • Founder of EmergingMoney.com

  • Chief Market Strategist for Virtus Investment Partners & CNBC Contributor

Halftime Report

Fast Money Features